← Leaderboards
Arun Shet
National Heart, Lung, And Blood Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Heart, Lung, And Blood Institute
Same institution · by research overlap
Others in their field
Top investigators on “Sickle Cell Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Martin H. Steinberg · Boston Medical Center$25,628,557
- Michael L. Terrin · Clinical Trials And Surveys Corporation$23,855,067
- Barbara L Kroner · Research Triangle Institute$21,141,016
- Garret A Fitzgerald · University Of Pennsylvania$20,602,198
Research focus
Sickle Cell AnemiaBiological MarkersCoagulation ProcessPlasmaExtracellular VesiclesBlood VesselsVenous ThrombosisGenerationsThrombinProtocols DocumentationSickle Cell TraitCellsLaboratoriesRecurrenceSamplingSicklingVenousFibrinSickle CellThromboplastinBloodDepositionInflammationThrombosis
Grant awards (15)
A Study to Evaluate the Effects of fixed dose Flavonoid Isoquercetin on thrombo-inflammatory biomarkers in subjects with stable Sickle Cell Disease$461,751
ZIA · FY2024 · HL · contact PI
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait$461,751
ZIA · FY2024 · HL · contact PI
A Study to Evaluate the Effects of fixed dose Flavonoid Isoquercetin on thrombo-inflammatory biomarkers in subjects with stable Sickle Cell Disease$572,243
ZIA · FY2023 · HL · contact PI
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait$228,897
ZIA · FY2023 · HL · contact PI
Human Specimen Collection to Support Basic and Clinical Research$228,897
ZIA · FY2023 · HL · contact PI
A Phase 1 Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects with stable sickle cell disease$114,449
ZIA · FY2023 · HL · contact PI
A Study to Evaluate the Effects of fixed dose Flavonoid Isoquercetin on thrombo-inflammatory biomarkers in subjects with stable Sickle Cell Disease$556,140
ZIA · FY2022 · HL · contact PI
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait$202,909
ZIA · FY2022 · HL · contact PI
Human Specimen Collection to Support Basic and Clinical Research$202,909
ZIA · FY2022 · HL · contact PI
A Study to Evaluate the Effects of fixed dose Flavonoid Isoquercetin on thrombo-inflammatory biomarkers in subjects with stable Sickle Cell Disease$427,227
ZIA · FY2021 · HL · contact PI
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait$256,336
ZIA · FY2021 · HL · contact PI
Human Specimen Collection to Support Basic and Clinical Research$170,891
ZIA · FY2021 · HL · contact PI
Human Specimen Collection to Support Basic and Clinical Research$316,764
ZIA · FY2020 · HL · contact PI
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait$256,841
ZIA · FY2020 · HL · contact PI
Human Specimen Collection to Support Basic and Clinical Research$303,742
ZIA · FY2019 · HL · contact PI